Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: TALECRIS BIOTHERAPEUTICS INC
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Cancelled Post Market | 02229695 | TALECRIS BIOTHERAPEUTICS INC | GAMIMUNE N 10% (IV) | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 100 MG / ML |
Cancelled Post Market | 02178842 | TALECRIS BIOTHERAPEUTICS INC | GAMIMUNE N 5% (IV) | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 50 MG / ML |
Cancelled Post Market | 02230920 | TALECRIS BIOTHERAPEUTICS INC | IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 10% | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 10 G / 100 ML |
Cancelled Post Market | 02230919 | TALECRIS BIOTHERAPEUTICS INC | IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 5% | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 5 G / 100 ML |
Application information
Related information
Contact us
Version 4.0.3